info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0145441-01
Couldn't load pickup availability
Vimseltinib (DCC-3014) is a c-FMS (CSF-IR) and c-Kit dual inhibitor extracted from patent WO2014145025A2, Compound Example 10, has IC50s of [1]. Vimseltinib has certain oral bioavailability[2].
[1628606-05-2]
C23H25N7O2
431.49
O=C1N(C)C(NC(C)C)=NC=C1C2=NC(C)=C(OC3=CC(C4=CN(C)N=C4)=NC=C3)C=C2
C-Fms; c-Kit
99.94
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
H315, H319
Loading...
Total items
Product subtotal
Vimseltinib is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.